Clinical Trial Update: Gene Therapy for Alpha 1- Antitrypsin Deficiency [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating a gene therapy for Alpha-1 antitrypsin deficiency, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alpha-1 Antitrypsin Deficiency

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Alpha 1-Antitrypsin Deficiency | Phase 1 | Status: RECRUITING